查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024803

血紅素檢測市場報告：按產品類型、技術、最終用戶和地區分類（2026-2034 年）

Hemoglobin Testing Market Report by Product Type (Reagents and Consumables, Equipment), Technology (Chromatography, Immunoassay, and Others), End-User (Laboratories, Hospitals, Research Centers), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血紅素檢測市場規模達27億美元，預計2034年將達到42億美元，2026年至2034年的複合年成長率為5.02%。糖尿病和貧血等慢性疾病的日益普遍是推動市場成長的主要因素。

血紅素檢測市場的發展趨勢：

對即時檢測（POC​​T）的需求日益成長

即時檢測 (POCT) 的出現標誌著血紅蛋白監測市場的一項重大進步，它使得在傳統檢查室之外進行快速便捷的檢測成為可能。攜帶式分析儀能夠快速提供檢測結果，有助於改善患者照護和決策。 2024 年 6 月，堀場公司推出了三款新型緊湊型血液分析儀：Yumizen H550E（自動進樣器）、H500E CT（封閉式試管）和 Yumizen H500E OT（開放式試管）。這些分析儀可在 60 秒內使用全血同時測量 CBC/DIFF（血液常規檢查/彌散）和 ESR（紅血球沉降速率）結果。

擴大人工智慧（AI）在診斷領域的應用

血紅蛋白檢測市場概覽重點在於人工智慧在血紅蛋白檢測領域的快速應用，旨在提高檢測的準確性和效率。人工智慧系統能夠快速評估大規模資料集，最大限度地減少人為錯誤，並提高診斷準確度。這是推動血紅素檢測市場發展的主要因素之一。 2024年8月，印度理工學院克勒格布爾分校與薩蒂亞·賽醫院合作進行人工智慧輔助的貧血篩檢計畫。該聯合計畫致力於開發創新解決方案，以應對弱勢群體面臨的貧血挑戰。

提高對貧血的認知並擴大篩檢

早期發現貧血（一種以血紅素水平低為特徵的疾病）變得越來越重要。世界各國政府和衛生組織正在啟動針對孕婦和兒童等高風險族群的篩檢計畫。 2024年2月，印度小兒科會（IAP）發起了一項全國性宣傳活動，旨在提高大眾對貧血和其他重要兒童健康議題的意識提升。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血紅素檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品類型
  • 市場區隔：依技術分類
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 試劑和耗材
  • 裝置

第7章 市場區隔：依技術分類

  • 層析法
  • 免疫檢測
  • 其他

第8章 市場區隔：依最終用戶分類

  • 研究所
  • 醫院
  • 研究機構

第9章 市場區隔：依地區分類

  • 歐洲
  • 北美洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • Danaher
    • EKF Diagnostics
    • F. Hoffmann-La Roche
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Alere
    • ACON Laboratories
    • ARKRAY
    • Bayer Medical Care
    • Daiichi Biotech
    • DiaSys Diagnostic Systems
    • Epinex Diagnostics
    • Erba Diagnostics
Product Code: SR112026A1306

The global hemoglobin testing market size reached USD 2.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.02% during 2026-2034. An increase in chronic conditions, including diabetes and anemia, is stimulating the market.

HEMOGLOBIN TESTING MARKET ANALYSIS:

  • Major Market Drivers: Improving healthcare systems, growing annual expenditure on medical services, increasing awareness of blood-related illnesses, and advancements in technology are some of the hemoglobin testing market growth drivers.
  • Key Market Trends: The rise of home-based testing driven by a growing desire for patient-centered treatment is a significant growth-inducing factor.
  • Competitive Landscape: Some of the prominent players in the market include Abbott Laboratories, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Alere, ACON Laboratories, ARKRAY, Bayer Medical Care, Daiichi Biotech, DiaSys Diagnostic Systems, Epinex Diagnostics, and Erba Diagnostics, among many others.
  • Geographical Trends: The market in North America is expanding due to enhanced medical infrastructure and an increased prevalence of diabetes and anemia. In Europe, there is widespread use of point-of-care testing and substantial funding from the government for healthcare programs. In Asia Pacific, burgeoning healthcare awareness and population growth are driving significant market progress. Market expansion in the Middle East and Africa is being driven by improved healthcare access and increased diagnostics investment. Latin America's market is expanding due to improved healthcare systems and a greater emphasis on rectifying nutritional inadequacies.
  • Challenges and Opportunities: The high price of modern devices for testing hinders the market. However, increasing investment in economical point-of-care equipment and improving healthcare access in low-income areas will continue to catalyze the market during the forecast period.

HEMOGLOBIN TESTING MARKET TRENDS:

Rising Demand for Point-of-Care Testing

The shift to point-of-care testing (POCT) is a significant development in the hemoglobin monitoring market as it provides quick, convenient testing outside of traditional labs. Portable analyzers deliver quick results, which improves patient care and decision-making. In June 2024, Horiba launched new compact hematology analyzers, namely, Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube). They offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.

Growing Use of Artificial Intelligence (AI) in Diagnostics

The hemoglobin testing market overview is exploring AI, which is rapidly being used in hemoglobin testing to improve accuracy and efficiency. AI-powered systems can swiftly evaluate big datasets, minimizing human error and improving diagnosis accuracy. This is one of the hemoglobin testing market drivers. In August 2024, IIT Kharagpur collaborated with Sathya Sai Hospital for AI-powered anemia screening. This joint effort focuses on developing innovative solutions to address the challenges of anemia in underprivileged populations.

Increasing Awareness and Screening for Anemia

Early identification of anemia, a disorder associated with low hemoglobin levels, is becoming increasingly important. Governments and health organizations around the world are launching screening programs to identify anemia in susceptible populations, such as pregnant women and children. In February 2024, the Indian Academy of Pediatrics (IAP) launched a nationwide campaign to raise awareness about anemia and other crucial child health issues.

GLOBAL HEMOGLOBIN TESTING INDUSTRY SEGMENTATION:

Breakup by Product Type:

  • Reagents and Consumables
  • Equipment

As per the hemoglobin testing market share analysis, reagents and consumables, such as test strips and other disposable materials, have a strong presence in the market due to their widespread use in diagnostic procedures. The equipment segment, which includes analyzers and point-of-care devices, is experiencing considerable growth due to technical developments and rising demand for portable testing solutions.

Breakup by Technology:

  • Chromatography
  • Immunoassay
  • Others

Chromatography is frequently utilized for precise and thorough hemoglobin variant analysis, especially in laboratory settings where precision is crucial. Meanwhile, immunoassay technology is gaining popularity because of its speed and cost-effectiveness, making it ideal for point-of-care testing and routine hemoglobin monitoring in a variety of healthcare settings. These segments are contributing to shaping hemoglobin testing market dynamics.

Breakup by End-User:

  • Laboratories
  • Hospitals
  • Research Centers

According to the hemoglobin testing industry statistics, laboratories hold a considerable proportion due to their ability to do high-volume testing and extensive analysis. Hospitals play an important role in hemoglobin testing for patient diagnosis and monitoring. Moreover, research institutions contribute to market growth by developing new testing methods and diagnostic technologies.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

As per the hemoglobin testing market outlook, advanced healthcare systems and extensive diagnostic tool usage are pushing the market in North America. Europe benefits from strong government healthcare assistance and heightened awareness of early detection. Asia Pacific is experiencing rapid growth due to its large population, rising healthcare awareness, and improving medical infrastructure. In Latin America, the market is growing as healthcare systems improve and focus on malnutrition-related illnesses. The Middle East and Africa region is evolving, with more access to healthcare, increased investment in diagnostics, and initiatives to tackle regional health challenges such as anemia.

COMPETITIVE LANDSCAPE:

The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Alere
  • ACON Laboratories
  • ARKRAY
  • Bayer Medical Care
  • Daiichi Biotech
  • DiaSys Diagnostic Systems
  • Epinex Diagnostics
  • Erba Diagnostics

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemoglobin Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Chromatography
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunoassay
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
    • 14.3.2 Bio-Rad Laboratories
    • 14.3.3 Danaher
    • 14.3.4 EKF Diagnostics
    • 14.3.5 F. Hoffmann-La Roche
    • 14.3.6 Siemens Healthineers
    • 14.3.7 Thermo Fisher Scientific
    • 14.3.8 Alere
    • 14.3.9 ACON Laboratories
    • 14.3.10 ARKRAY
    • 14.3.11 Bayer Medical Care
    • 14.3.12 Daiichi Biotech
    • 14.3.13 DiaSys Diagnostic Systems
    • 14.3.14 Epinex Diagnostics
    • 14.3.15 Erba Diagnostics

List of Figures

  • Figure 1: Global: Hemoglobin Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Hemoglobin Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Hemoglobin Testing Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Hemoglobin Testing Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Hemoglobin Testing Market: Breakup by End-User (in %), 2025
  • Figure 6: Global: Hemoglobin Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Hemoglobin Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Hemoglobin Testing Industry: SWOT Analysis
  • Figure 9: Global: Hemoglobin Testing Industry: Value Chain Analysis
  • Figure 10: Global: Hemoglobin Testing Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Hemoglobin Testing (Reagents and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Hemoglobin Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Hemoglobin Testing (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Hemoglobin Testing (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Hemoglobin Testing (Chromatography) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Hemoglobin Testing (Chromatography) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Hemoglobin Testing (Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Hemoglobin Testing (Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Hemoglobin Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Hemoglobin Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Hemoglobin Testing (Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Hemoglobin Testing (Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Hemoglobin Testing (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Hemoglobin Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Hemoglobin Testing (Research Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Hemoglobin Testing (Research Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Europe: Hemoglobin Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Europe: Hemoglobin Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Hemoglobin Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Hemoglobin Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Asia Pacific: Hemoglobin Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Asia Pacific: Hemoglobin Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Middle East and Africa: Hemoglobin Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Middle East and Africa: Hemoglobin Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Latin America: Hemoglobin Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Latin America: Hemoglobin Testing Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Hemoglobin Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Hemoglobin Testing Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Hemoglobin Testing Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 4: Global: Hemoglobin Testing Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Hemoglobin Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Hemoglobin Testing Market Structure
  • Table 7: Global: Hemoglobin Testing Market: Key Players